Format

Send to

Choose Destination
See comment in PubMed Commons below
Stroke. 2009 Nov;40(11):e614-21. doi: 10.1161/STROKEAHA.108.520858. Epub 2009 Aug 13.

Defeating normal thermoregulatory defenses: induction of therapeutic hypothermia.

Author information

1
Department of Outcomes Research, The Cleveland Clinic, Cleveland, Ohio 44195, USA. DS@OR.org

Abstract

Therapeutic hypothermia may be useful in various circumstances including stroke. However, core body temperature is normally tightly regulated. Even mild hypothermia in conscious subjects thus provokes vigorous thermoregulatory defenses which are potentially harmful in fragile patients. Furthermore, thermoregulatory responses are effective, which reduces the rate at which hypothermia can be induced. Drugs are thus often given to blunt normal thermoregulatory defenses. General anesthetics profoundly impair thermoregulatory control, but prolonged general anesthesia is rarely practical or appropriate. A variety of other drugs have therefore been evaluated. Most opioids only slightly impair thermoregulatory defenses, but meperidine is considerably more effective than equipotent doses of other opioids. The central alpha-2 agonists clonidine and dexmedetomidine are also useful. However, the best overall approach to inducing thermal tolerance appears to be a combination of buspirone and meperidine, which reduces the core temperature triggering shivering to about 33.5 degrees C in doses that maintain adequate ventilation.

PMID:
19679849
DOI:
10.1161/STROKEAHA.108.520858
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center